Cours Heron Therapeutics Inc OTC Bulletin Board
Actions
APPAD
US4277461020
Recherche biotechnologique et médicale
CA 2024 * | 148 M 131 M | CA 2025 * | 178 M 157 M | Capitalisation | 527 M 466 M |
---|---|---|---|---|---|
Résultat net 2024 * | -14 M -12,38 M | Résultat net 2025 * | 1 M 884 k | VE / CA 2024 * | 3,57 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 2,96 x |
PER 2024 * |
-38,9
x | PER 2025 * |
525
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 99,3% |
Dernier transcript sur Heron Therapeutics Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/02/23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16/06/23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/11/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/02/23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20/09/21 |
Craig Johnson
BRD | Director/Board Member | 62 | 13/01/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+24,74% | 47,54 Md | |
-0,47% | 41,96 Md | |
+46,11% | 41,55 Md | |
+25,40% | 30,36 Md | |
+17,96% | 27,61 Md | |
-4,47% | 28,7 Md | |
+50,73% | 14,7 Md | |
+42,56% | 13,51 Md | |
+1,46% | 12,34 Md |